RPG Life Sciences Ltd

NSE: RPGLIFE · BSE: 532983 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹3,050.60
Market cap: ₹5,045 Cr
Revenue (annual): ₹707.5 Cr
Net profit (annual): ₹115.2 Cr
P/E (TTM): 42.2×Sector 50.4×
Promoter holding: 72.95%+0.00% QoQ
FII holding: 0.95%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 4 Acquisition 2 Price Movement Clarification 1 Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Sep 2026 21:36 IST NSE

Acquisition

RPG Life Sciences Acquisition

RPG Life Sciences completed its acquisition of the entire stake in Actis Generics Private Limited, making it a subsidiary of the company.

Read the filing ↗

2 Sep 2026 22:23 IST NSE

Acquisition

RPG Life Sciences Acquisition Worth ₹135 Cr

RPG Life Sciences' subsidiary, RPG Active Pharma, will acquire the API business of Raghava Life Sciences for up to ₹135 Crore, expanding its manufacturing capabilities.

Value: ₹135.0 Cr
manufacturing capacity: 300.0 KL

Read the filing ↗